Medications: Some prescription drugs have fatigue as a side effect
Similarly, in the combined case-control and cohort study by Wium-Andersen and colleagues, 33 low doses of metformin, DPP-4 inhibitors, GLP-1 analogs, and SGLT2 inhibitors were associated with a lower risk of depression in patients with diabetes compared to non users, with the lowest risk for sodium-glucose transport protein 2 inhibitor users
This property enables ALCAR to influence central nervous system functions, including neurotransmitter synthesis, mitochondrial energy metabolism in neurons, and neuroprotection [2][5]
At baseline, participants had: At 72 weeks , participants receiving the high-dose semaglutide + bimagrumab combination experienced: Thats a huge shift compared to the 60/40 or 75/25 ratios we see with GLP-1 monotherapy